نتایج جستجو برای: tp53 mutation and expression

تعداد نتایج: 16973495  

2014
Rita A. Busuttil Giada V. Zapparoli Sue Haupt Christina Fennell Stephen Q. Wong Jia-Min B. Pang Elena A. Takeno Catherine Mitchell Natasha Di Costanzo Stephen Fox Ygal Haupt Alexander Dobrovic Alex Boussioutas

Intestinal metaplasia (IM) is a premalignant lesion associated with gastric cancer (GC) but is poorly described in terms of molecular changes. Here, we explored the role of TP53, a commonly mutated gene in GC, to determine if p53 protein expression and/or the presence of somatic mutations in TP53 can be used as a predictive marker for patients at risk of progressing to GC from IM. Immunohistoch...

Journal: :Oncotarget 2015
Ji Yun Lee Kyunghee Park Sung Hee Lim Hae Su Kim Kwai Han Yoo Ki Sun Jung Haa-Na Song Mineui Hong In-Gu Do TaeJin Ahn Se Kyung Lee Soo Youn Bae Seok Won Kim Jeong Eon Lee Seok Jin Nam Duk-Hwan Kim Hae Hyun Jung Ji-Yeon Kim Jin Seok Ahn Young-Hyuck Im Yeon Hee Park

Although breast cancer is the second most common cause of brain metastasis with a notable increase of incidence, genes that mediate breast cancer brain metastasis (BCBM) are not fully understood. To study the molecular nature of brain metastasis, we performed gene expression profiling of brain metastasis and matched primary breast cancer (BC). We used the Ion AmpliSeq Cancer Panel v2 covering 2...

2015
Chi Young Ok Keyur P Patel Guillermo Garcia-Manero Mark J Routbort Jie Peng Guilin Tang Maitrayee Goswami Ken H Young Rajesh Singh L Jeffrey Medeiros Hagop M Kantarjian Rajyalakshmi Luthra Sa A Wang

BACKGROUND TP53 mutation is more prevalent in therapy-related myeloid neoplasms (t-MN) than their de novo counterparts; however, the pattern of mutations involving TP53 gene in t-MN versus de novo diseases is largely unknown. METHODS We collected 108 consecutive patients with therapy-related myelodysplastic syndrome (t-MDS)/acute myeloid leukemia (t-AML). Clinical, hematological, and cytogene...

2017
Jolien Van den Bossche Christophe Deben Ken Op de Beeck Vanessa Deschoolmeester Christophe Hermans Ines De Pauw Julie Jacobs Paul Van Schil Jan Baptist Vermorken Patrick Pauwels Marc Peeters Filip Lardon An Wouters

Background: Currently, prognosis of non-small cell lung cancer (NSCLC) patients is based on clinicopathological factors, including TNM stage. However, there are considerable differences in patient outcome within a similar staging group, even when patients received identical treatments. In order to improve prognostic predictions and to guide treatment options, additional parameters influencing o...

Journal: :Cell 2012
Tobias Rausch David T.W. Jones Marc Zapatka Adrian M. Stütz Thomas Zichner Joachim Weischenfeldt Natalie Jäger Marc Remke David Shih Paul A. Northcott Elke Pfaff Jelena Tica Qi Wang Luca Massimi Hendrik Witt Sebastian Bender Sabrina Pleier Huriye Cin Cynthia Hawkins Christian Beck Andreas von Deimling Volkmar Hans Benedikt Brors Roland Eils Wolfram Scheurlen Jonathon Blake Vladimir Benes Andreas E. Kulozik Olaf Witt Dianna Martin Cindy Zhang Rinnat Porat Diana M. Merino Jonathan Wasserman Nada Jabado Adam Fontebasso Lars Bullinger Frank G. Rücker Konstanze Döhner Hartmut Döhner Jan Koster Jan J. Molenaar Rogier Versteeg Marcel Kool Uri Tabori David Malkin Andrey Korshunov Michael D. Taylor Peter Lichter Stefan M. Pfister Jan O. Korbel

Genomic rearrangements are thought to occur progressively during tumor development. Recent findings, however, suggest an alternative mechanism, involving massive chromosome rearrangements in a one-step catastrophic event termed chromothripsis. We report the whole-genome sequencing-based analysis of a Sonic-Hedgehog medulloblastoma (SHH-MB) brain tumor from a patient with a germline TP53 mutatio...

Journal: :Cancer research 2001
C Wiese S S Gauny W C Liu C L Cherbonnel-Lasserre A Kronenberg

Allelic loss is an important mutational mechanism in human carcinogenesis. Loss of heterozygosity (LOH) at an autosomal locus is one outcome of the repair of DNA double-strand breaks (DSBs) and can occur by deletion or by mitotic recombination. We report that mitotic recombination between homologous chromosomes occurred in human lymphoid cells exposed to densely ionizing radiation. We used cell...

2015
Sebastian Ribi Daniel Baumhoer Kristy Lee Edison Audrey S.M. Teo Babita Madan Kang Zhang Wendy K. Kohlmann Fei Yao Wah Heng Lee Qiangze Hoi Shaojiang Cai Xing Yi Woo Patrick Tan Gernot Jundt Jan Smida Michaela Nathrath Wing-Kin Sung Joshua D. Schiffman David M. Virshup Axel M. Hillmer

Somatic mutations of TP53 are among the most common in cancer and germline mutations of TP53 (usually missense) can cause Li-Fraumeni syndrome (LFS). Recently, recurrent genomic rearrangements in intron 1 of TP53 have been described in osteosarcoma (OS), a highly malignant neoplasm of bone belonging to the spectrum of LFS tumors. Using whole-genome sequencing of OS, we found features of TP53 in...

2016
Silvia Darb-Esfahani Carsten Denkert Albrecht Stenzinger Christoph Salat Bruno Sinn Christian Schem Volker Endris Peter Klare Wolfgang Schmitt Jens-Uwe Blohmer Wilko Weichert Markus Möbs Hans Tesch Sherko Kümmel Peter Sinn Christian Jackisch Manfred Dietel Toralf Reimer Sherene Loi Michael Untch Gunter von Minckwitz Valentina Nekljudova Sibylle Loibl

BACKGROUND TP53 mutations are frequent in breast cancer, however their clinical relevance in terms of response to chemotherapy is controversial. METHODS 450 pre-therapeutic, formalin-fixed, paraffin-embedded core biopsies from the phase II neoadjuvant GeparSixto trial that included HER2-positive and triple negative breast cancer (TNBC) were subjected to Sanger sequencing of exons 5-8 of the T...

2011
Heath D. Skinner Vlad C. Sandulache Thomas J. Ow Raymond E. Meyn John S. Yordy Beth M. Beadle Alison L. Fitzgerald Uma Giri K. Kian Ang Jeffrey N. Myers

Purpose: Mortality of patients with head and neck squamous cell carcinoma (HNSCC) is primarily driven by tumor cell radioresistance leading to locoregional recurrence (LRR). In this study, we use a classificationofTP53mutation (disruptive vs. nondisruptive) and examine impact on clinical outcomes and radiation sensitivity. Experimental Design: Seventy-four patients with HNSCC treated with surge...

2016
Chung-Hsin Chen Kathleen G. Dickman Chao-Yuan Huang Chia-Tung Shun Huai-Ching Tai Kuo-How Huang Shuo-Meng Wang Yuan-Ju Lee Arthur P. Grollman Yeong-Shiau Pu

TP53 mutation patterns are associated with prognosis of various cancers. This study was designed to investigate the association between TP53 mutation patterns and recurrence patterns in upper urinary tract urothelial carcinoma (UTUC) patients. A total of 165 consecutive UTUC patients who underwent nephroureterectomies were enrolled for measuring mutation patterns of TP53 gene from exome 2 to 11...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید